血液造血干细胞移植或酶替代疗法在高氏病3型
Astrid Høj1, Mette Cathrine Ørngreen2, Marie Mostue Naume2
1Center for Inherited Metabolic Diseases, Departments of Paediatrics and Adolescent Medicine and Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark and European Reference Network for Hereditary Metabolic Disorders (MetabERN), Copenhagen, Denmark; Copenhagen Neuromuscular Center Department 8077, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Molecular genetics and metabolism
|June 23, 2024
概括
血液造血干细胞移植 (HSCT) 显示,与酶替代疗法 (ERT) 相比,Gaucher病3型 (GD3) 兄弟姐妹的神经结果更好. HSCT使生物标志物正常化,而ERT没有防止神经衰退.
科学领域:
- 遗传学和罕见疾病.
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- 氏病 (Gaucher disease,简称GD) 是一种溶酶体储存障碍,其特征是葡萄糖脑化物积累.
- GD被分为三种类型,其中GD3是一种神经病变形式.
- 酶替代疗法 (ERT) 有效地管理非神经GD3症状,但无法穿越血脑屏障以阻止神经进展.
研究的目的:
- 为了比较三个GD3兄弟姐妹的一般性,神经认知和生化结果,他们接受了ERT或HSCT治疗.
- 评估HSCT与ERT在管理GD3.D的神经表现方面的长期疗效.
主要方法:
- 对三名患有GD3的兄弟姐妹进行了回顾性分析,所有人都对GBA1c.1448T>C变异具有同胞性.
- 两个兄弟姐妹 (HSCT1,HSCT2) 接受了HSCT,而一个 (ERT1) 接受了ERT.
- 评估神经认知状态,神经表现,以及血和脑脊液 (CSF) 中的胆三酶水平.
主要成果:
- 接受ERT治疗的兄弟姐妹 (ERT1) 经历了神经认知能力的下降,包括发作和精神障碍.
- 一个接受HSCT治疗的兄弟姐妹 (HSCT1) 在神经学上没有受到影响,而另一个 (HSCT2) 患有听力损失和低智商.
- 在HSCT接受者中,奇托里奥酶水平正常化,但在ERT接受者中仍然升高.
结论:
- 与ERT相比,HSCT在GD3患者中表现出优异的神经结果和生物标志物正常化.
- 在HSCT的进步需要重新考虑它作为GD3的主要治疗方法,以改善神经结果.
- 在神经病变的高希氏病中,HSCT可能提供一种更有效的策略来限制疾病进展.
更多相关视频
相关概念视频
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


